![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/20 | |
A61K 31/485 | |||
C07D 489/08 |
(11) | Number of the document | 2371357 |
(13) | Kind of document | T |
(96) | European patent application number | 11157837.3 |
Date of filing the European patent application | 2011-03-11 | |
(97) | Date of publication of the European application | 2011-10-05 |
(45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
313018 P | 2010-03-11 | US |
(72) |
Shah, Syed M., US
Diorio, Christopher Richard, US
Ehrnsperger, Eric C., US
Meng, Xu, US
Shareffi, Kadum A., US
Cohen, Jonathan Marc, US
|
(73) |
Wyeth LLC,
235 East 42nd Street, New York, NY 10017,
US
|
(54) | Oral formulations and lipophilic salts of methylnaltrexone |
Oral formulations and lipophilic salts of methylnaltrexone |